Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Upstream Bio, Inc. (NASDAQ: UPB)
UPB Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-35.80%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
384.90%
UPB Stock Analysis
UPB
PE Ratio:
UPB
PEG Ratio:
Not Available
UPB
Forward EPS Growth (12 month):
0.00%
UPB
PS Ratio:
125
UPB
PSG Ratio:
-8
UPB
Forward Revenue Growth (12 month):
-15.60%
UPB Articles
No data was found